Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-014556)

Filing Details

Accession Number:: 0001209191-10-014556
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-04 12:00:00
Reporting Period:: 2010-03-02

Filing Date:: 2010-03-04
Accepted Time:: 2010-03-04 17:10:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1047699	King Pharmaceuticals Inc	KG	Pharmaceutical Preparations (2834)	541684963

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1257960	Jr Frederick Brouillette	501 Fifth Street Bristol TN 37620	Corporate Compliance Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-03-02	6,190	$8.91	100,632	No	4	M	Direct
Common Stock	Disposition	2010-03-02	6,190	$11.42	94,442	No	4	S	Direct
Common Stock	Disposition	2010-03-02	11,066	$11.42	83,376	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2010-03-02	6,190	$0.00	6,190	$8.91

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,570		2018-03-25	No	4	M	Direct

Footnotes

The Stock Options exercised vested on March 25, 2009. Thirty-three percent of the remaining original award of Stock Options will vest on March 25, 2010 and 34% will vest on March 25, 2011.